Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality

被引:3
|
作者
Na, Hee Young [1 ]
Kim, Jee Hyun [2 ]
Kim, Haeryoung [3 ]
Cho, Jai Young [4 ]
Han, Ho-Seong [4 ]
Jang, Eun Sun [5 ]
Kim, Jin-Wook [5 ]
Jeong, Sook-Hyang [5 ]
Heo, Jayoon [2 ,6 ]
Kim, Ji-Won [2 ]
Kim, Jin Won [2 ]
Ahn, Soomin [1 ,7 ,8 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Coll Med, Seongnam, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Med Oncol,Bundang Hosp, Seongnam, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul Natl Univ Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Surg, Seongnam, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Bundang Hosp, Seongnam, South Korea
[6] Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Goyang, South Korea
[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[8] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol & Translat Genom, Sch Med, 81 Irwon ro, Seoul 06351, South Korea
关键词
combined hepatocellular-cholangiocarcinoma; intermediate cell carcinoma; liver; next-generation sequencing; CARCINOMA;
D O I
10.1111/his.15081
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of liver tumour that exhibits both hepatocytic and biliary differentiation within the same tumour. The histology and genomic alterations of recurrent/metastatic cHCC-CC are poorly understood. We selected six patients with cHCC-CC whose recurrent or metastatic tumours were histologically confirmed. Four patients with classic cHCC-CCs and two with intermediate cell carcinomas (ICs) were included. The clinicopathological features were evaluated, and next-generation sequencing was performed in 17 multiregional and longitudinal tumour samples. The histology of recurrent/metastatic lesions of classic cHCC-CCs was variable: hepatocellular carcinoma (HCC) was observed in one (25.0%) patient, cHCC-CC in one (25.0%) patient, and cholangiocarcinoma (CC) in two (50.0%) patients. Among 13 samples from four classic cHCC-CC patients, the most frequent pathological variants were TP53 (46.2%), TERT promoter (38.5%), ARID1A mutations (23.1%), and MET amplification (30.8%). In the sequencing analysis of each HCC and CC component, three (75.0%) of the four classic cHCC-CCs shared pathogenic variants. A large proportion of mutations, both pathogenic and those of undetermined significance, were shared by each HCC and CC component. Regarding ICs, the ATM mutation was detected in one patient. In conclusion, the histology of recurrent/metastatic cHCC-CCs was heterogeneous. Genomic profiling of classic cHCC-CCs revealed similar genomic alterations to those of HCC. Considerable overlapping genomic alterations in each HCC and CC component were observed, suggesting a monoclonal origin. Genetic alterations in ICs were different from those in either HCC or CC, suggesting the distinct nature of this tumour. The histology of recurrent/metastatic tumours of cHCC-CCs was variable. Genomic profiling of cHCC-CC revealed considerable overlapping genomic alterations in each HCC and CC component.image
引用
收藏
页码:402 / 408
页数:7
相关论文
共 50 条
  • [1] COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA - A HISTOLOGIC AND IMMMUNOHISTOCHEMICAL STUDY
    GOODMAN, ZD
    ISHAK, KG
    LANGLOSS, JM
    SESTERHENN, IA
    RABIN, L
    CANCER, 1985, 55 (01) : 124 - 135
  • [2] Combined hepatocellular-cholangiocarcinoma: An update
    Reig, Maria
    Cabibbo, Giuseppe
    JOURNAL OF HEPATOLOGY, 2021, 74 (05) : 1225 - 1233
  • [3] Combined hepatocellular-cholangiocarcinoma in a cow
    Honda, Hidetsugu
    Kiku, Yoshio
    Mikami, Osamu
    Ishikawa, Yoshiharu
    Kadota, Koichi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2020, 82 (01): : 84 - 88
  • [4] Combined hepatocellular-cholangiocarcinoma diagnosis
    Carvalho, L.
    Ladeirinha, A. F.
    Alarcao, A.
    Neves, L.
    Santos, R.
    Santo, J. Espirito
    VIRCHOWS ARCHIV, 2020, 477 : S273 - S273
  • [5] Pathology of combined hepatocellular-cholangiocarcinoma
    Yeh, Matthew M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (09) : 1485 - 1492
  • [6] Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma
    Joseph, Nancy M.
    Tsokos, Christos G.
    Umetsu, Sarah E.
    Shain, A. Hunter
    Kelley, Robin K.
    Onodera, Courtney
    Bowman, Sarah
    Talevich, Eric
    Ferrell, Linda D.
    Kakar, Sanjay
    Krings, Gregor
    JOURNAL OF PATHOLOGY, 2019, 248 (02): : 164 - 178
  • [7] Cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in cirrhotic patients
    Salinas, Marcelo
    Simian, Daniela
    Carreno, Laura
    Cattaneo, Maximo
    Urzua, Alvaro
    Saure, Alex
    Lembach, Hanns
    Castillo, Jaime
    Diaz, Juan C.
    Poniachik, Jaime
    REVISTA MEDICA DE CHILE, 2022, 150 (11) : 1431 - 1437
  • [8] MOLECULAR HETEROGENEITY IN COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA: A SMALL CASE SERIES
    Santo, Joana Espirito
    Ladeirinha, Ana
    Alarcao, Ana
    Neves, Lia
    Strelet, Eugeniu
    Reis, Marco
    Santos, Rui
    Carvalho, Lina
    HEPATOLOGY, 2022, 76 : S1270 - S1270
  • [9] Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations
    Ahmed, Naghia
    Falcinelli, Francesca
    Rimini, Margherita
    Burgio, Valentina
    Casadei-Gardini, Andrea
    Aldrighetti, Luca
    Ratti, Francesca
    Pedica, Federica
    HEPATOMA RESEARCH, 2023, 9
  • [10] Rapidly Progressive Combined Hepatocellular-Cholangiocarcinoma
    Balassiano, Natalie
    Asad, Omar
    Saliaj, Merjona
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2341 - S2341